How do ADHD medications affect memory recall?

PostedDecember 25, 2025

UpdatedJanuary 2, 2026

ByMy Patient Advice

Author: Harriet Winslow, BSc | Reviewed by: Dr. Rebecca Fernandez, MBBS

ADHD medications are often prescribed to improve concentration, attention, and executive function, but many people wonder how these treatments influence memory recall. According to NHS guidance, medicines such as methylphenidate and lisdexamfetamine increase activity in brain regions linked to attention and behaviour. While these medications can sharpen focus and reduce impulsivity, their impact on memory is more nuanced. Evidence from systematic reviews between 2020 and 2025 shows that stimulants and non-stimulants can modestly enhance short-term and working memory, but effects on long-term recall appear limited.

How ADHD medicines influence memory

Research consistently shows that ADHD medications, when taken as prescribed, can improve specific aspects of cognitive performance. According to the NICE NG87 guideline, methylphenidate or lisdexamfetamine are first-line treatments for most people with ADHD, aiming to reduce functional impairment and support attention, organisation, and memory skills.

Stimulants and memory recall

Studies, including a 2024 King’s College London meta-analysis, found that stimulants like methylphenidate produce small improvements in working memory and attention while taken. The benefits are often task-specific and tend to fade when treatment stops. Stimulants appear to enhance short-term and visual–spatial working memory by improving focus and reducing cognitive lapses. However, evidence suggests that long-term episodic memory, the ability to recall events or detailed information, does not improve significantly once medication is discontinued.

Side effects such as sleep disturbance, appetite changes, and anxiety can indirectly affect concentration and memory performance. Shared-care protocols from the NHS recommend ongoing dose review to ensure optimal cognitive benefit while minimising these risks.

Atomoxetine and memory

Atomoxetine, a non-stimulant medication, also supports working memory and sustained attention, though its effects develop more gradually. Reviews published in Frontiers in Human Neuroscience indicate that atomoxetine enhances activation in brain areas associated with working memory and inhibitory control. According to the Royal College of Psychiatrists, atomoxetine can be particularly effective for individuals who experience side effects from stimulants or require steadier day-long coverage. While there is limited evidence of long-term memory enhancement, improved consistency and attention can support better information recall in daily life.

For those seeking private ADHD assessment and post-diagnostic medication reviews, services like ADHD Certify provide clinician-led evaluations aligned with NICE and NHS standards.

Key takeaway

Current evidence suggests that ADHD medications, particularly stimulants and atomoxetine, can modestly improve attention and working memory during treatment. These benefits often translate into better day-to-day focus and organisation rather than major gains in long-term memory recall. There is no robust evidence that ADHD medicines harm memory at therapeutic doses, though effects vary between individuals. Ongoing clinical review, lifestyle adjustments, and behavioural strategies such as memory training and structured routines remain essential for long-term cognitive support.

According to NICE and NHS experts, ADHD medication should always be part of a broader management plan that includes psychological, educational, and behavioural interventions to help individuals reach their full potential.

Harriet Winslow, BSc

Author

Harriet Winslow is a clinical psychologist with a Bachelor’s in Clinical Psychology and extensive experience in behaviour therapy and developmental disorders. She has worked with children and adolescents with ADHD, autism spectrum disorder (ASD), learning disabilities, and behavioural challenges, providing individual and group therapy using evidence-based approaches such as CBT and DBT. Dr. Winslow has developed and implemented personalised treatment plans, conducted formal and informal assessments, and delivered crisis intervention for clients in need of urgent mental health care. Her expertise spans assessment, treatment planning, and behavioural intervention for both neurodevelopmental and mental health conditions.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the author's privacy.

Dr. Rebecca Fernandez, MBBS

Reviewer

Dr. Rebecca Fernandez is a UK-trained physician with an MBBS and experience in general surgery, cardiology, internal medicine, gynecology, intensive care, and emergency medicine. She has managed critically ill patients, stabilised acute trauma cases, and provided comprehensive inpatient and outpatient care. In psychiatry, Dr. Fernandez has worked with psychotic, mood, anxiety, and substance use disorders, applying evidence-based approaches such as CBT, ACT, and mindfulness-based therapies. Her skills span patient assessment, treatment planning, and the integration of digital health solutions to support mental well-being.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the reviewer's privacy.